4 or more fertile days2
There are various early pregnancy symptoms,
like tiredness and cravings, and they differ
from woman to woman, and from pregnancy to pregnancy.
Find out how to identify fertile days to
achieve conception and understand the
importance of timing with Clearblue
*The World's No: 1 selling brand in home pregnancy & fertility tests.
Based on international sales compiled using independent market research data (data on file).
Pregnancy and Ovulation Tests
Clearblue tests can help you find the answers you are looking for by providing clear results with accuracy and convenience. Our current range of products includes pregnancy tests, ovulation tests.
Over the past 33 years over 23,000 volunteers have been involved in Clearblue clinical research in more than 140 trials. We are committed to helping you manage your reproductive health.
How to get pregnant ?
You can only get pregnant if you have unprotected sex during the few days each menstrual cycle leading up to and including the day of ovulation. So, if you are trying to conceive Clearblue Ovulation Tests enable you to identify these fertile days helping you to get pregnant faster
Am I pregnant ?
Various early pregnancy symptoms can indicate you might be pregnant. They differ from woman to woman and from pregnancy to pregnancy. If you are pregnant, you may notice one or more of these symptoms or none at all. That’s why Clearblue® Ultra Early Pregnancy Test can be used up to 6 days before your missed period, which is 5 days before the day you would expect your period to start (your ‘expected period’ day).4
Over 30 years of World firsts from the pregnancy and fertility category experts. The Clearblue brand has a history of more than 30 years of innovation, giving women confidence and reassurance. That’s why over 20 million women choose our products every year and over 30 million women visit our website to find the answers they need.
We put women right at the heart of everything we do – from education and technological development through to design, research, clinical studies, field trials and testing. Our mission is to transform the way women manage their reproductive health.
For over 30 years we have helped millions of women across the globe by delivering accurate & clear answers at life-changing moments. Whether trying to conceive or thinking they may be pregnant, we have been supporting women with innovative Clearblue products to manage their reproductive life.
First one-step pregnancy test
Launch of first one-step ovulation test
World’s first digital pregnancy test by Clearblue
World’s first pregnancy test that indicates when a woman conceived
- … all from Clearblue
Our team of trained Clearblue careline advisors are here to help. Whether you have a simple technical question about one of our products or want friendly advice to help you on your journey to parenthood, our dedicated team of professionals is here for you.
We engage with a range of independent Healthcare Professionals to continue to ensure our scientific and educational understanding is up-to-date with the latest scientific and clinical trends. Our independent experts also critique our Clearblue product-related activities. Our Advisory Board is made up of a range of fertility, pregnancy, contraception and sexual health experts with a broad range of experience
Professor William Ledger is Head of Discipline of Obstetrics and Gynaecology of the Faculty of Medicine at the University of New South Wales, Director of Reproductive Medicine and Senior Staff Specialist at the Royal Hospital for Women and a fertility specialist at City Fertility in Sydney. He founded the Fertility and Research Centre (FRC), a joint venture between University of New South Wales and South East Sydney Local Health District as a centre for translational research in reproductive biology and reproductive medicine.
He is Chair of the RANZCOG Research Committee and a member of the Scientific Advisory Committee of the Fertility Society of Australia. He is also Chair of the Postgraduate Board of the Discipline of Obstetrics and Gynaecology, which manages Masters programs in Reproductive Medicine and in Women’s Health Medicine. He is a member of the Editorial Board of 8 scientific journals and has a h-index of 50 (Scopus) and 48 (Web of Science). He is author of 344 journal articles and 17 books (6 authored, 11 edited).
Cecilia Bottomley is a Consultant Gynaecologist at Chelsea and Westminster Hospital (since 2009) where she leads the Early Pregnancy Unit. She has authored or co-authored over 30 peer reviewed papers in top impact Obstetrics and Gynaecology Journals and now regularly peer reviews for several journals. For many years Cecilia has lectured nationally and internationally on early pregnancy and emergency gynaecology and is a medical advisor to the Ectopic Pregnancy Trust.
Professor Nick Macklon is Professor of Obstetrics and Gynaecology at the University of Southampton and the University of Copenhagen. He is also Scientific Director of the Complete Fertility Centre Southampton. Professor Macklon has published more than 170 Pubmed cited articles in the fields of ovarian stimulation and endometrial receptivity. He has also published three books, including the award winning IVF in the Medically Complicated Patient, and the Textbook of Peri-conceptional Medicine
Jill Shawe is Professor of Maternal & Family Healthcare and Director of the Centre for Research in Nursing and Midwifery Education (CRNME) at the University of Surrey. She works clinically as a Reproductive Health Nurse and Midwife specialising in fertility awareness. Her research interests include preconception and postnatal care and she is currently researching the issues of diabetes, weight management and pregnancy. She has been instrumental in forming a European Pre-pregnancy Research Collaboration to promote preconception and fertility awareness in Europe.
Emma Kirk is a Consultant in Obstetrics and Gynaecology at the Royal Free London, where she is the Lead for Early Pregnancy and Emergency Gynaecology. She has a special interest in Early Pregnancy and Gynaecological Ultrasound. She worked as a research fellow for many years and has published over 50 peer reviewed papers on early pregnancy topics. She has written many book chapters and edited her own book on Early Pregnancy Ultrasound. Emma is Coordinator of the European Society of Human Reproduction and Embryology Special Interest Group in Early Pregnancy. She is on the board of the association of early pregnancy units (AEPU) and is a medical advisor to the ectopic pregnancy trust (EPT). She frequently lectures on different aspects of early pregnancy.
Dr Gnoth is director of Gynaecological Endocrinology and Reproductive Medicine at Green-IVF in Grevenbroich, Germany and professor in obstetrics and gynaecology at the University of Cologne. Dr Gnoth is author of more than 50 scientific papers, 2 textbooks and several book chapters on infertility, periconceptional gynaecology, infertility treatment, especially reproductive endocrinology. He is also a member of the board of trustees of the German IVF Register (DIR).
Chris Wilkinson is the Lead Consultant in Sexual and Reproductive Healthcare at the Margaret Pyke Centre, London. He is the President of the Faculty of Sexual & Reproductive Healthcare (FSRH) the leading national body that sets standards and awards qualifications in SRH in the UK, which has approximately 15,000 medical members. Dr Wilkinson is a member of the UK Sexual and Reproductive Clinical Research Network and is closely involved in developing the research programme.
- Weeks since conception shown as 1-2, 2-3 or 3+ on screen
- In a study of 87 women, 4 or more fertile days were identified in 80% of cycles using actual cycle length (2012.
- The World's No: 1 selling brand in home pregnancy & fertility tests. Based on international sales compiled using independent market research data (data on file).
- Clearblue Ultra Early. ’Missed Period’ refers to the day after the day you expect your period. In lab testing 79% of pregnant results were detected 5 days before the expected period, 96% were detected 4 days before and >99% were detected from 3 days before the expected period.